AMGEN TO PRESENT AT THE 43RD ANNUAL TD COWEN HEALTHCARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at the 2023 TD Cowen Healthcare Conference on March 8, 2023, at 11:10 a.m. ET. The presentation will feature Murdo Gordon and Peter H. Griffith, executive vice presidents at Amgen. The event will be accessible via a live webcast for media, investors, and the public. Interested parties can find details on Amgen’s website under Investors, with the presentation archived for 90 days post-event. Amgen has been a pioneer in biotechnology since 1980, focusing on innovative therapies for serious illnesses and is recognized as one of the Dow Jones Industrial Average companies.

THOUSAND OAKS, Calif., March 3, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2023 TD Cowen Healthcare Conference at 11:10 a.m. ET on Wednesday, March 8, 2023. Murdo Gordon, executive vice president of Global Commercial Operations and Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2022, Amgen was named one of the "World's Best Employers" by Forbes and one of "America's 100 Most Sustainable Companies" by Barron's.

For more information, visit Amgen.com and follow us on Twitter, LinkedIn, Instagram, TikTok and YouTube.  

CONTACT: Amgen, Thousand Oaks 
Jessica Akopyan, 805-447-0974 (media) 
Arvind Sood, 805-447-1060 (investors) 

 

View original content:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-43rd-annual-td-cowen-healthcare-conference-301761178.html

SOURCE Amgen

FAQ

When will Amgen present at the TD Cowen Healthcare Conference?

Amgen will present at the TD Cowen Healthcare Conference on March 8, 2023, at 11:10 a.m. ET.

Who will represent Amgen at the 2023 TD Cowen Healthcare Conference?

Murdo Gordon and Peter H. Griffith, both executive vice presidents at Amgen, will represent the company.

How can I watch Amgen's presentation at the TD Cowen Healthcare Conference?

Amgen's presentation can be watched via a live webcast available on their website under the Investors section.

Will the Amgen presentation be available for replay?

Yes, the webcast of Amgen's presentation will be archived and available for replay for at least 90 days after the event.

What is Amgen's focus as a biotechnology company?

Amgen focuses on discovering and developing innovative human therapeutics for serious illnesses, leveraging advanced human genetics.